Follow-The-Filings

Holders · period archive

PRME · Prime Medicine Inc.

Q2 2024 13F holders among managers we track latest ownership dossier

Ticker
PRME
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares